Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 75,410 | 129,122 | 8,140 | -6,408 | -31,383 |
| Depreciation Amortization | -1,485 | 120 | 108 | 177 | 170 |
| Income taxes - deferred | 14,067 | -76,703 | N/A | N/A | N/A |
| Accounts receivable | -2,288 | -5,440 | -3,639 | -2,887 | -1,906 |
| Accounts payable and accrued liabilities | -389 | 6,289 | 965 | -561 | -495 |
| Other Working Capital | 3,926 | -5,714 | 1,156 | 500 | -5,042 |
| Other Operating Activity | 26,424 | 13,261 | 11,661 | 12,309 | 11,280 |
| Operating Cash Flow | $115,665 | $60,935 | $18,391 | $3,130 | $-27,376 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 142,655 | 29,950 | N/A | N/A | N/A |
| PPE Investments | -298 | -419 | -194 | -17 | -174 |
| Purchase Of Investment | -233,124 | -102,987 | N/A | N/A | N/A |
| Investing Cash Flow | $-90,767 | $-73,456 | $-194 | $-17 | $-174 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -15,134 | -14,779 | -9,207 | -4,856 |
| Common Stock Issued | 9,322 | 7,181 | 7,683 | 22,281 | 1,777 |
| Common Stock Repurchased | -23,657 | 0 | 0 | N/A | N/A |
| Financing Cash Flow | $-14,335 | $-7,953 | $-7,096 | $13,074 | $-3,079 |
| Beginning Cash Position | 31,062 | 51,536 | 40,435 | 24,248 | 54,877 |
| End Cash Position | 41,625 | 31,062 | 51,536 | 40,435 | 24,248 |
| Net Cash Flow | $10,563 | $-20,474 | $11,101 | $16,187 | $-30,629 |
| Free Cash Flow | |||||
| Operating Cash Flow | 115,665 | 60,935 | 18,391 | 3,130 | -27,376 |
| Capital Expenditure | -298 | -419 | -194 | -17 | -174 |
| Free Cash Flow | 115,367 | 60,516 | 18,197 | 3,113 | -27,550 |